Market Overview

athenahealth to Acquire Epocrates for $11.75/Share in Cash

Related ATHN
New Survey Gives J.P. Morgan Confidence To Go Overweight Athenahealth, Allscripts & Advisory Board
Morning Market Losers
3 Industry Groups Show Strength, Rise Through Ranks (Investor's Business Daily)


Inc. (NASDAQ: ATHN), a leading provider of cloud-based electronic
health record (EHR),
practice management, and care
coordination services to medical groups and health systems, today
announced that it has signed a definitive agreement to acquire
Epocrates (NASDAQ: EPOC), a mobile health pioneer widely recognized for developing
the most-widely adopted point-of-care medical application among U.S.

The board of directors of each of athenahealth and Epocrates has agreed
to a price of $11.75 per share, in cash, for an aggregate purchase price
of approximately $293 million. The purchase price represents a 22
percent premium over the closing price per share of Epocrates on NASDAQ

See full press release

Posted-In: News Guidance Contracts Management Global


Related Articles (ATHN + EPOC)

Get Benzinga's Newsletters